GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System
Building on 25 years of TEVAR experience we’ve combined a proven stent graft with controlled, staged deployment, uniquely designed for trusted conformability and anatomical adaptability.
We create solutions engineered to perform as promised.
“Gore has a long history with TEVAR. We look back on 25 years and think of all the milestones. There's been an enduring benefit to patients over a long period of time.”
- Michael D. Dake, M.D.*
“They were the first ones to come out with a TEVAR device, and a branch arch device, and a dissection indication. They have a whole series of firsts for us and our patients.”
- Joseph E. Bavaria, M.D.*
From the first FDA approved thoracic device to future development, we are TEVAR.
“Gore really helped pioneer these devices and advance the technology and make it applicable to everyday treatment of these patients.”
- Darren B. Schneider, M.D.*
“The first time I used the [GORE® TAG® Thoracic Endoprosthesis ] I was a resident. Fast forward 20 years, what we are doing now, we couldn't even think about it.”
- Gustavo Oderich, M.D.*
Deliberately designed to enable long-term results you can trust and your patients count on.
Featured Resources
Why Oversizing Windows Matter
Video
Essential sizing overview for thoracic etiologies
Hemodynamic Flow Animation
Video
Demostrates the continuous blood flow throughout deployment of the stent graft* Paid consultant for Gore.
INDICATIONS FOR USE IN THE U.S.: The GORE® TAG® Conformable Thoracic Stent Graft is intended for endovascular repair of all lesions of the descending thoracic aorta, including: isolated lesions in patients who have appropriate anatomy, including: adequate iliac/femoral access, aortic inner diameter in the range of 16-42 mm, ≥ 20 mm non-aneurysmal aorta proximal and distal to the lesion; Type B dissections in patients who have appropriate anatomy, including: adequate iliac/femoral access, ≥ 20 mm landing zone proximal to the primary entry tear; proximal extent of the landing zone must not be dissected, diameter at proximal extent of proximal landing zone in the range of 16-42 mm.
CONTRAINDICATIONS: Patients with known sensitivities or allergies to the device materials; patients who have a condition that threatens to infect the graft. Refer to Instructions for Use at eifu.goremedical.com for a complete description of all applicable indications, warnings, precautions and contraindications for the markets where this product is available. RXOnly
241338755-EN
